Tradestie Institutional Equity Comparison Engine

VSSYW vs ABVX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABVX Overall Edge

ABVX Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abivax SA American Depositary Shares (ABVX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VSSYW trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ABVX at N/M Forward P/E and -6270.4% operating margin (-6.8% YoY). In options structure, VSSYW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
VSSYW N/M vs ABVX N/M Fwd P/E
Growth & Margin Winner ABVX
Op Margin N/A vs -6270.4% ยท YoY N/A vs -6.8%
Momentum & Technical Winner ABVX
1Y -49.8% vs -35.2% ยท 52W Pos 24% vs 12%
Options & Structure Winner ABVX
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
VSSYW US Equity
VSSYW
Institutional Equity
$0.01
-34.74% 1D
Market Cap N/A
1M Return -49.8%
1Y Return -49.8%
Forward P/E N/M
Unified AI Score
46.2 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
ABVX NASDAQ
Abivax SA American Depositary Shares
Pharmaceutical Preparations
$73.20
-9.24% 1D
Market Cap $7.1B
1M Return -18.87%
1Y Return -35.19%
Forward P/E N/M
Unified AI Score
42.4 / 100 HOLD
Tech 25.0 Fund 38.0 Flow 50.0 Mom 30.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VSSYW -49.8% ABVX -35.19% Spread: +42.95 pp (ABVX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VSSYW TTM Op. Margin: N/A ABVX TTM Op. Margin: -6270.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VSSYW vs ABVX. Trailing 12-month operating profitability (VSSYW N/A vs ABVX -6270.4%) and valuation multiples (VSSYW N/M vs ABVX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VSSYW (2) vs ABVX (6)
Institutional Metric VSSYW ABVX Criterion Row Winner
Market Capitalization Scale N/A $7.1B Larger Scale ABVX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A -6.8% Higher Growth ABVX
Operating Margin (TTM) Profitability N/A -6270.4% Higher Margin ABVX
Net Profit Margin Profitability N/A 0.0% Higher Margin ABVX
Return on Equity (ROE) Capital Efficiency N/A -252.3% Higher ROE ABVX
52-Week Range Position Momentum 24% ($0โ€“$0) 12% ($63โ€“$149) Stronger Trend VSSYW
Beta / 30D Volatility Risk Regime N/A 1.55ฮฒ ยท 55% Vol Lower Realized Risk ABVX
Unified Institutional Score Composite Signal 46.2 / 100 (HOLD) 42.4 / 100 (HOLD) Higher Composite VSSYW

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VSSYW vs ABVX Buy Guide
VSSYW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VSSYW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABVX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ABVX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VSSYW nor ABVX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.